Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
5(26%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
5%
Ph not_applicable
11
58%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(10)
Other(2)

Detailed Status

Completed10
Recruiting4
unknown2
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (8.3%)
N/A11 (91.7%)

Trials by Status

completed1053%
unknown211%
active_not_recruiting15%
not_yet_recruiting211%
recruiting421%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07172334

What is the Role of the Exposome in Pulmonary Hypertension

Not Yet Recruiting
NCT03984708Not Applicable

New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.

Completed
NCT02670226Not Applicable

Muscular Biomarkers in Amyotrophic Lateral Sclerosis

Completed
NCT02573974Not Applicable

Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer

Completed
NCT03027479Not Applicable

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss

Completed
NCT07173829

A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

Not Yet Recruiting
NCT01719510Not Applicable

Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningitis

Completed
NCT05463796

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting
NCT04666090Phase 2

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Active Not Recruiting
NCT05733845Not Applicable

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

Recruiting
NCT06007534Not Applicable

Pharmacokinetic Characterization of a Single 200 mg Dose of Doxycycline in Post-exposure Prophylaxis (PEP) of Sexually Transmitted Infections in Different Biological Compartments

Recruiting
NCT04099082

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans

Recruiting
NCT03216252Not Applicable

DNA QUANTIFICATION TECHNIQUE AS A INTERPRETATION TOOL IN MITOCHONDRIAL DISEASES

Completed
NCT05629299Not Applicable

Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM

Unknown
NCT03492606

Lipid Mediators in Multiple Sclerosis

Completed
NCT03497481

Neopterin Dosage in the Eye

Completed
NCT03751930

Intestinal Microbiota, Tryptophan and Autism

Completed
NCT04705389Not Applicable

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

Unknown
NCT02809222Not Applicable

Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls

Completed

All 19 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
19